l929 fibroblast cell line (ATCC)
Structured Review

L929 Fibroblast Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 3278 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/l929+cell+lines/NCTC+clone+929/pmc13670397-134-1-8
Average 99 stars, based on 3278 article reviews
Images
1) Product Images from "Impact of Plant Pre‐Processing on the Chemical Profile of Psidium guajava L. (Myrtaceae) Essential Oil and Evaluation of Its Bioactive Potential"
Article Title: Impact of Plant Pre‐Processing on the Chemical Profile of Psidium guajava L. (Myrtaceae) Essential Oil and Evaluation of Its Bioactive Potential
Journal: Chemistry & Biodiversity
doi: 10.1002/cbdv.71843
Figure Legend Snippet: Cell viability of L929 murine fibroblasts after 48 h of exposure to the leaf essential oils of Psidium guajava L. obtained under different pre‐processing conditions, determined by the MTT assay. Panels A–D correspond to EOFH‐S, EOFH‐M, EOFZ‐S and EOFZ‐M, respectively (concentrations in µg/mL); the horizontal line marks 70% viability. Data are expressed as mean ± SD; differences versus the negative control were assessed by one‐way ANOVA followed by Bonferroni's post hoc test ( n = 3, performed in triplicate; GraphPad Prism 5.0); * p < 0.05 and ** p < 0.01 versus the negative control. Essential oils obtained from fresh leaves fragmented with scissors (EOFH‐S) or ground in a mixer (EOFH‐M). Essential oils obtained from previously frozen leaves fragmented with scissors (EOFZ‐S) or ground in a mixer (EOFZ‐M).
Techniques Used: MTT Assay, Negative Control
Related Articles
Cell Culture:Article Title: Cross-linker engineered poly(hydroxyethyl methacrylate) hydrogel allows photodynamic and photothermal therapies and controlled drug release. Article Snippet: Here, we disclose the synthesis of poly(2-hydroxyethyl methacrylate) (PHEMA) hydrogels incorporating a squaraine dye (Sq) as a chemical crosslinker, viz.. Sq@PHEMA.. Photothermal and photodynamic features of Sq@PHEMA hydrogels are evaluated in detail. Article Title: POLY(N-ISOPROPYLACRYLAMIDE) HYDROGEL INCORPORATING SQUARAINE: SYNTHESIS, DRUG DELIVERY AND PHOTODYNAMIC PROPERTIES Article Snippet: .. DMEM (100 μl) containing 10% FBS and 1% penicillin/streptomycin was added to 96-well plates, and 25x103 cells per well were cultured at 37°C by incubating in a 5% CO2 environment overnight in Produced:Article Title: Polyclonal B cells acquire LCMV antigens in a GP1-dependent manner Article Snippet: .. LCMV Armstrong 53b (originally obtained from Dr. Rolf M. Zinkernagel) was produced on BHK21 (ATCC CCL-10), MC57G (ATCC CRL-2296) or Article Title: Polyclonal B cells acquire LCMV antigens in a GP1-dependent manner. Article Snippet: .. LCMV Armstrong 53b (originally obtained from Dr. Rolf M. Zinkernagel) was produced on BHK21 (ATCC CCL-10), MC57G (ATCC CRL-2296) or In Vitro:Article Title: Design, synthesis, and molecular modeling of novel thiazolopyridine-based inhibitors of enoyl acyl carrier protein reductase (InhA) as anti- Mycobacterium tuberculosis agents Article Snippet: .. The in vitro cytotoxicity evaluation of the tested compounds was performed after 24-hour incubation in compliance with international guidelines (ISO 10993-5:2009(E)) utilizing Incubation:Article Title: Design, synthesis, and molecular modeling of novel thiazolopyridine-based inhibitors of enoyl acyl carrier protein reductase (InhA) as anti- Mycobacterium tuberculosis agents Article Snippet: .. The in vitro cytotoxicity evaluation of the tested compounds was performed after 24-hour incubation in compliance with international guidelines (ISO 10993-5:2009(E)) utilizing MTT Assay:Article Title: Design, synthesis, and molecular modeling of novel thiazolopyridine-based inhibitors of enoyl acyl carrier protein reductase (InhA) as anti- Mycobacterium tuberculosis agents Article Snippet: .. The in vitro cytotoxicity evaluation of the tested compounds was performed after 24-hour incubation in compliance with international guidelines (ISO 10993-5:2009(E)) utilizing |